ZYME
Price:
$22.88
Market Cap:
$1.68B
Zymeworks Inc. is a biopharmaceutical firm in the clinical development phase, dedicated to identifying, advancing, and bringing to market biological therapies aimed at combating cancer. Its pipeline features two primary experimental treatments: zanidatamab, a cutting-edge bispecific antibody currently undergoing Phase 1 and Phase 2 studies for various malignancies such as those affecting the biliary tract, gastroesophageal region (adenocarcinomas), breast, and colon; and ZW49, an antibody-drug conjugate targeting two sites on the human epidermal growth factor receptor 2 (HER2), which is in Phase 1 trials for advanced or spreading tumors that express HER2. Zymeworks maintains significant alli...[Read more]
Industry
Biotechnology
IPO Date
2017-04-28
Stock Exchange
NASDAQ
Ticker
ZYME
According to Zymeworks Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 1.46B. This represents a change of 1.88% compared to the average of 1.43B of the last 4 quarters.
The mean historical Enterprise Value of Zymeworks Inc. over the last ten years is 893.84M. The current 1.46B Enterprise Value has changed 16.19% with respect to the historical average. Over the past ten years (40 quarters), ZYME's Enterprise Value was at its highest in in the December 2020 quarter at 2.18B. The Enterprise Value was at its lowest in in the June 2016 quarter at 0.
Average
893.84M
Median
634.78M
Minimum
125.46M
Maximum
2.15B
Discovering the peaks and valleys of Zymeworks Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 318.71%
Maximum Annual Enterprise Value = 2.15B
Minimum Annual Increase = -79.61%
Minimum Annual Enterprise Value = 125.46M
| Year | Enterprise Value | Change |
|---|---|---|
| 2025 | 1.96B | 84.49% |
| 2024 | 1.06B | 81.78% |
| 2023 | 584.65M | 318.71% |
| 2022 | 139.63M | -79.61% |
| 2021 | 684.90M | -68.11% |
| 2020 | 2.15B | 33.83% |
| 2019 | 1.60B | 318.16% |
| 2018 | 383.76M | 205.87% |
| 2017 | 125.46M | -48.59% |
| 2016 | 244.04M | -0.94% |
The current Enterprise Value of Zymeworks Inc. (ZYME) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
1.20B
5-year avg
886.55M
10-year avg
893.84M
Zymeworks Inc.’s Enterprise Value is greater than Maze Therapeutics, Inc. (1.19B), less than Ardelyx, Inc. (1.58B), less than Spyre Therapeutics, Inc. (4.78B), less than Pharvaris N.V. (1.60B), greater than Intellia Therapeutics, Inc. (1.30B), less than BioCryst Pharmaceuticals, Inc. (2.51B), greater than Immunome, Inc. (1.18B), less than Trevi Therapeutics, Inc. (2.00B), greater than Wave Life Sciences Ltd. (600.52M), greater than Upstream Bio, Inc. (236.35M),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 1.19B | $1.33B | |
| 1.58B | $1.41B | |
| 4.78B | $4.88B | |
| 1.60B | $2.15B | |
| 1.30B | $1.36B | |
| 2.51B | $1.83B | |
| 1.18B | $1.76B | |
| 2.00B | $2.02B | |
| 600.52M | $1.13B | |
| 236.35M | $331.96M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Zymeworks Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Zymeworks Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Zymeworks Inc.'s Enterprise Value?
What is the highest Enterprise Value for Zymeworks Inc. (ZYME)?
What is the 3-year average Enterprise Value for Zymeworks Inc. (ZYME)?
What is the 5-year average Enterprise Value for Zymeworks Inc. (ZYME)?
How does the current Enterprise Value for Zymeworks Inc. (ZYME) compare to its historical average?